Human African trypanosomiasis

Handbook of Clinical Neurology

Volumn 114, Issue , 2013, Pages 169-181

  Lejon, Veerle ^a   Bentivoglio, Marina ^b   Franco, José Ramon ^c  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY OF VERONA   (Italy)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Clinical; Control; Diagnosis; Human African trypanosomiasis; Pathogenesis; Sleeping sickness; Treatment; Trypanosoma brucei gambiense; Trypanosoma brucei rhodesiense; Tsetse fly

Indexed keywords

EID: 84879849677     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53490-3.00011-X     Document Type: Chapter

References (81)

1. Amin D.N., Rottenberg M.E., Thomson A.R., et al. Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis. J Infect Dis 2009, 200:1556-1565.
2. Amrouni D., Gautier-Sauvigne S., Meiller A., et al. Cerebral and peripheral changes occurring in nitric oxide (NO) synthesis in a rat model of sleeping sickness: identification of brain iNOS expressing cells. PLoS One 2010, 5:e9211.
3. Bailey J.W., Smith D.H. The use of the acridine orange QBC technique in the diagnosis of African trypanosomiasis. Trans R Soc Trop Med Hyg 1992, 86:630.
4. Balasegaram M., Harris S., Checchi F., et al. Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo. Bull World Health Organ 2006, 84:777-782.
5. Bentivoglio M., Kristensson K. Neural-immune interactions in disorders of sleep-wakefulness organization. Trends Neurosci 2007, 30:645-652.
6. Blum J., Nkunku S., Burri C. Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis. Trop Med Int Health 2001, 6:390-400.
7. Blum J., Schmid C., Burri C. Clinical aspects of 2541 patients with second stage human African trypanosomiasis. Acta Trop 2006, 97:55-64.
8. Blum J.A., Schmid C., Hatz C., et al. Sleeping glands? The role of endocrine disorders in sleeping sickness (T.b. gambiense Human African Trypanosomiasis). Acta Trop 2007, 104:16-24.
9. Blum J.A., Schmid C., Burri C., et al. Cardiac alterations in human African trypanosomiasis (T.b. gambiense) with respect to the disease stage and antiparasitic treatment. PLoS Negl Trop Dis 2009, 3:e383.
10. Brandenberger G., Buguet A., Spiegel K., et al. Disruption of endocrine rhythms in sleeping sickness with preserved relationship between hormonal pulsatility and the REM-NREM sleep cycles. J Biol Rhythms 1996, 11:258-267.
11. Bray P.G., Barrett M.P., Ward S.A., et al. Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. Trends Parasitol 2003, 19:232-239.
12. Brun R., Schumacher R., Schmid C., et al. The phenomenon of treatment failures in human African trypanosomiasis. Trop Med Int Health 2001, 6:906-914.
13. Brun R., Blum J., Chappuis F., et al. Human African trypanosomiasis. Lancet 2009, 375:148-159.
14. Buguet A., Tapie P., Bert J. Reversal of the sleep/wake cycle disorder of sleeping sickness after trypanosomicide treatment. J Sleep Res 1999, 8:225-235.
15. Buguet A., Bourdon L., Bouteille B., et al. The duality of sleeping sickness: focusing on sleep. Sleep Med Rev 2001, 5:139-153.
16. Buguet A., Bisser S., Josenando T., et al. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness. Acta Trop 2005, 93:107-117.
17. Büscher P., Mumba Ngoyi D., Kaboré J., et al. Improved models of mini anion exchange centrifugation technique (mAECT) and modified single centrifugation (MSC) for sleeping sickness diagnosis and staging. PLoS Negl Trop Dis 2009, 3:e471.
18. Büscher P., Guilleman Q., Lejon V. Rapid diagnostic test for sleeping sickness. N Engl J Med 2013.
19. Camara M., Camara O., Ilboudo H., et al. Sleeping sickness diagnosis: use of buffy coats improves the sensitivity of the mini anion exchange centrifugation test. Trop Med Int Health 2010, 15:796-799.
20. Chappuis F. Melarsoprol-free drug combinations for second-stage gambian sleeping sickness: The way to go. Clin Infect Dis 2007, 45:1443-1445.
21. Chappuis F., Loutan L., Simarro P., et al. Options for the field diagnosis of human African trypanosomiasis. Clin Microbiol Rev 2005, 18:133-146.
22. Chappuis F., Udayraj N., Stietenroth K., et al. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis. Clin Infect Dis 2005, 41:748-751.
23. Checchi F., Filipe J.A.N., Barrett M.P., et al. The natural progression of gambiense sleeping sickness: What is the evidence?. PLoS Negl Trop Dis 2008, 2:e303.
24. Checchi F., Filipe J.A.N., Haydon D.T., et al. Estimates of the duration of the early and late stage of gambiense sleeping sickness. BMC Infect Dis 2008, 8:16.
25. Chimelli L., Scaravilli F. Trypanosomiasis. Brain Pathol 1997, 7:599-611.
26. Chisi J.E., Misiri H., Zverev Y., et al. Anaemia in human African trypanosomiasis caused by Trypanosoma brucei rhodesiense. East Afr Med J 2004, 81:505-508.
27. Claustrat B., Buguet A., Geoffriau M., et al. Plasma melatonin rhythm is maintained in human African trypanosomiasis. Neuroendocrinology 1998, 68:64-70.
28. Dauvilliers Y., Bisser S., Chapopot F., et al. Hypocretin and human African trypanosomiasis. Sleep 2008, 31:348-354.
29. Deborggraeve S., Büscher P. Molecular diagnostics for sleeping sickness: where's the benefit for the patient?. Lancet Infect Dis 2010, 10:433-439.
30. Deborggraeve S., Lejon V., Ali Ekangu R., et al. Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study. PLoS Negl Trop Dis 2011, 5:e972.
31. Drugs for Neglected Disease Initiative DNDi R&D Projects-2011 Outlook 2011, (accessed 5 Sept 2011). http://www.dndi.org/index.php/portfolio.html?ids=2.
32. Dukes P., Rickman L.R., Killick-Kendrick R., et al. A field comparison of seven diagnostic techniques for human trypanosomiasis in the Luangwa Valley, Zambia. Tropenmed Parasitol 1984, 35:141-147.
33. Dumas M., Bisser S. Clinical aspects of human African trypanosomiasis. Progress in human African Trypanosomiasis Sleeping Sickness 1999, 215-233. Springer, Paris. M. Dumas, B. Bouteille, A. Buguet (Eds.).
34. Ehrhardt S., Lippert U., Burchard G.D., et al. Orchitis as an unusual manifestation of human African trypanosomiasis. J Infect 2006, 52:e31-e33.
35. Fairlamb A.H. Chemotherapy of human African trypanosomiasis: current and future prospects. Trends Parasitol 2003, 19:488-494.
36. Greenwood B.M., Whittle H.C. The pathogenesis of sleeping sickness. Trans R Soc Trop Med Hyg 1980, 74:716-725.
37. Henry M.C., Kageruka P., Ruppol J.F., et al. Evaluation du diagnostic sur le terrain de la trypanosomiase à Trypanosoma brucei gambiense. Ann Soc Belg Med Trop 1981, 61:79-92.
38. Jenkins G.C., Facer C.A. Haematology of African trypanosomiasis. Immunology and Pathogenesis of Trypanosomiasis 1985, 13-44. CRC Press, Boca Raton. I. Tizard (Ed.).
39. Kager P.A., Schipper H.G., Stam J., et al. Magnetic resonance imaging findings in human African trypanosomiasis: a four-year follow-up study in a patient and review of the literature. Am J Trop Med Hyg 2009, 80:947-952.
40. Kazyumba G., Berney M., Brighouse G., et al. Expression of the B cell repertoire and autoantibodies in human African trypanosomiasis. Clin Exp Immunol 1986, 65:10-18.
41. Kennedy P.G.E. Human African trypanosomiasis. Practical Neurology 2005, 5:260-267.
42. Kennedy P.G. Human African trypanosomiasis: neurological aspects. J Neurol 2006, 253:411-416.
43. Kennedy P.G.E. The continuing problem of human African trypanosomiasis (sleeping sickness). Ann Neurol 2008, 64:116-127.
44. Kristensson K., Nygard M., Bertini G., et al. African trypanosome infections of the nervous system: parasite entry and effects on sleep and synaptic functions. Prog Neurobiol 2010, 91:152-171.
45. Küpfer I.S. Improved melarsoprol therapy for Trypanosoma brucei rhodesiense sleeping sickness 2009, PhD thesis, University of Basel. http://edoc.unibas.ch/1118/.
46. Küpfer I., Hhary E.P., Allan M., et al. Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda. PLoS Negl Trop Dis 2011, 5:e968.
47. Legros D., Ollivier G., Gastellu-Etchegorry M., et al. Treatment of human African trypanosomiasis: present situation and needs for research and development. Lancet Infect Dis 2002, 2:437-440.
48. Lejon V., Büscher P. Cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post-treatment follow-up. Trop Med Int Health 2005, 10:395-403.
49. Lejon V., Reiber H., Legros D., et al. Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis. J Infect Dis 2003, 187:1475-1483.
50. Lejon V., Mumba Ngoyi D., Boelaert M., et al. A CATT negative result after treatment for human African trypanosomiasis is no indication for cure. PLoS Negl Trop Dis 2010, 4:e590.
51. Lumsden W.H.R., Kimber C.D., Dukes P., et al. Field diagnosis of sleeping sickness in the Ivory Coast. I. Comparison of the miniature anion-exchange/centrifugation technique with other protozoological methods. Trans R Soc Trop Med Hyg 1981, 75:242-250.
52. Lutumba P., Robays J., Miaka C., et al. Validité, coÛt et faisabilité de la mAECT et CTC comme tests de confirmation dans la détection de la trypanosomiase humaine Africaine. Trop Med Int Health 2006, 2:470-478.
53. MacLean L.M., Odiit M., Chisi J.E., et al. Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense. PLoS Negl Trop Dis 2010, 4:e906.
54. Magnus E., Vervoort T., Van Meirvenne N. A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T.b.gambiense trypanosomiasis. Ann Soc Belg Méd Trop 1978, 58:169-176.
55. Masocha W., Rottenberg M.E., Kristensson K. Migration of African trypanosomes across the blood-brain barrier. Physiol Behav 2007, 92:110-114.
56. Miézan T.W., Meda A.H., Doua F., et al. Evaluation des techniques parasitologiques utilisées dans le diagnostic de la trypanosomose humaine à Trypanosoma gambiense en CÔte d'Ivoire. Bull Soc Pathol Exot Fil 1994, 87:101-104.
57. Miézan T.W., Meda A.H., Doua F., et al. Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive detection of trypanosomes. Trans R Soc Trop Med Hyg 2000, 94:293.
58. Mumba Ngoyi D., Lejon V., Pyana P., et al. How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness?. J Infect Dis 2010, 201:453-463.
59. Njamnshi A.K., Seke Etet P.F., Perrig S., et al. Actigraphy in human African trypanosomiasis as a tool for objective clinical evaluation and monitoring: a pilot study. PLoS Negl. Trop. Dis. 2012, 6:e1525.
60. Nozais J.P. Mais ou es donc passée la "clé de Kérandel"?. Bull Soc Pathol Exot Filiales 1988, 81:477-479.
61. Odiit M., Kanshme F., Enyaru J.C.K. Duration of symptoms and case fatality of sleeping sickness caused by Trypansoma brucei rhodesiense in Tororo, Uganda. East Afr Med J 1997, 74:792-795.
62. Pays E. Regulation of antigen gene expression in Trypanosoma brucei. Trends Parasitol 2005, 21:517-520.
63. Pépin J., Milord F. The treatment of human African trypanosomiasis. Adv Parasitol 1994, 33:2-49.
64. Priotto G., Kasparian S., Mutombo W., et al. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet 2009, 374:56-64.
65. Radomski M.W., Buguet A., Doua F., et al. Relationship of plasma growth hormone to slow-wave sleep in African sleeping sickness. Neuroendocrinology 1996, 63:393-396.
66. Robays J., Nyamowala G., Sese C., et al. High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo. Emerg Inf Dis 2008, 14:966-967.
67. Rodgers J. Trypanosomiasis and the brain. Parasitology 2010, 137:1995-2006.
68. Schmid C., Richer M., Bilengue M.M.C., et al. Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II). J Infect Dis 2005, 191:1922-1931.
69. Simarro P.P., Jannin J., Cattand P. Eliminating human African trypanosomiasis: Where do we stand and what comes next?. Public Library of Science Medicine 2008, 5:174-180.
70. Simarro P.P., Diarra A., Ruiz Postigo J.A., et al. The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward. PLoS Negl Trop Dis 2011, 5:e1007.
71. Simarro P.P., Franco J.R., Cecchi G., et al. Human African trypanosomiasis in non-endemic countries (2000-2010). J Travel Med 2012, 19:44-53.
72. Tiberti N., Hainard A., Lejon V., et al. Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis. Mol Cell Proteomics 2010, 9:2783-2795.
73. Tiberti N., Lejon V., Hainard A., et al. Neopterin is a new cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sickness. PLoS Negl Trop Dis 2013, 7:e2088.
74. Truc P., Bailey J.W., Doua F., et al. A comparison of parasitological methods for the diagnosis of gambian trypanosomiasis in an area of low endemicity in CÔte d'Ivoire. Trans R Soc Trop Med Hyg 1994, 88:419-421.
75. Truc P., Formenty P., Diallo P.B., et al. Confirmation of two distinct classes of zymodemes of Trypanosoma brucei infecting man and wild mammals in CÔte d'Ivoire: suspected difference in pathogenicity. Ann Trop Med Parasitol 1997, 91:951-956.
76. Truc P., Jamonneau V., N'Guessan P., et al. Parasitological diagnosis of human African trypanosomiasis: a comparison of the QBC and miniature anion-exchange centrifugation techniques. Trans R Soc Trop Med Hyg 1998, 92:288-289.
77. Winterbottom T.M. An Account of the Native Africans in the Neighbourhood of Sierra Leone 1803, C. Whittingham, London.
78. Woo P.T.K. The haematocrit centrifuge technique for the diagnosis of African trypanosomiasis. Acta Trop 1970, 27:384-386.
79. World Health Organization Control and surveillance of African trypanosomiasis. World Health Organ Tech Rep Ser 1998, 881:1-113.
80. World Health Organization WHO model list of essential medicines, 16th list March 2009 2009, World Health Organization, Geneva, (accessed 5 Sept 2011). http://www.who.int/medicines/publications/essentialmedicines/en/index.html.
81. World Health Organization New cases of human African trypanosomiasis continue to drop 2011, World Health Organization, Geneva, (accessed 5 Sept 2011). http://www.who.int/neglected_diseases/disease_management/HAT_cases_drop/en/.